Sarcopenia as a predictor of initial administration dose of afatinib in patients with advanced non‐small cell lung cancer

BACKGROUND: Sarcopenia has recently emerged as a new condition with increasing importance in lung cancer patients. The aim of this study was to investigate the influence of sarcopenia on tolerance and efficacy of afatinib. METHODS: We retrospectively evaluated 35 patients with epidermal growth facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Xin, Zhang, Ping, Gao, Jia‐Yin, Cheng, Gang, Liu, Wei, Li, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201527/
https://www.ncbi.nlm.nih.gov/pubmed/33951292
http://dx.doi.org/10.1111/1759-7714.13934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201527/
https://www.ncbi.nlm.nih.gov/pubmed/33951292
http://dx.doi.org/10.1111/1759-7714.13934

Ejemplares similares